Back to Journals » Clinical Ophthalmology » Volume 17

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence

Total article views   HTML views PDF downloads Totals
3,179 Dovepress* 2,783+ 84 2,867
PubMed Central* 396 93 489
Totals 3,179 177 3,356
*Since 8 April 2023
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar